SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
Abstract: Accurately predicting the occurrence, amplitude, and propagation speed of traffic flow shockwaves are essential for dynamic traffic control to mitigate traffic congestion. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback